These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 1838608)

  • 1. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS; Runice C; Dowd F
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
    Kilpatrick GJ; el Tayar N; Van de Waterbeemd H; Jenner P; Testa B; Marsden CD
    Mol Pharmacol; 1986 Sep; 30(3):226-34. PubMed ID: 2943980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.
    Meller E; Bohmaker K; Rosengarten H; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential binding properties of drugs for interactions with sub-unit sites of the rat striatal dopaminergic receptor.
    Van Gompel P; Geerts R; Leysen JE
    Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):327-30. PubMed ID: 6753776
    [No Abstract]   [Full Text] [Related]  

  • 7. [3H]haloperidol binding to more than one site in rat brain striatum.
    Helmeste DM; Seeman P
    Biochem Pharmacol; 1983 Feb; 32(4):741-4. PubMed ID: 6830638
    [No Abstract]   [Full Text] [Related]  

  • 8. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat.
    Pardo JV; Creese I; Burt DR; Snyder SH
    Brain Res; 1977 Apr; 125(2):376-82. PubMed ID: 851885
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidences for a direct action in striatum of dopaminergic receptor antagonists mediating DOPAC formation.
    Racagni G; Groppetti A; Parenti M; Bugatti A; Bruno F; Maggi A; Cattabeni F
    Life Sci; 1978 Oct; 23(17-18):1757-61. PubMed ID: 723449
    [No Abstract]   [Full Text] [Related]  

  • 10. Neostriatal dopamine receptors.
    De Keyser J; Ebinger G
    Trends Neurosci; 1990 Aug; 13(8):324-5. PubMed ID: 1699315
    [No Abstract]   [Full Text] [Related]  

  • 11. Calmodulin antagonists decrease the binding of epidermal growth factor to transformed, but not to normal, human fibroblasts.
    Bodine PV; Tupper JT
    Biochem J; 1984 Mar; 218(2):629-32. PubMed ID: 6324761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 3H-melatonin to calmodulin.
    Benítez-King G; Huerto-Delgadillo L; Antón-Tay F
    Life Sci; 1993; 53(3):201-7. PubMed ID: 8321083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human brain receptors,V. Binding and message.
    Meador-Woodruff JH; Watson SJ; Tamminga CA
    Am J Psychiatry; 1994 Jun; 151(6):804. PubMed ID: 8184989
    [No Abstract]   [Full Text] [Related]  

  • 14. Calmodulin mediates melatonin cytoskeletal effects.
    Benítez-King G; Antón-Tay F
    Experientia; 1993 Aug; 49(8):635-41. PubMed ID: 8359270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin binding to D2 receptors in rat striatum: a comparative study with calmodulin antagonists.
    Chávez JL; Antón-Tay F; Benítez-King G
    Proc West Pharmacol Soc; 1991; 34():413-6. PubMed ID: 1838608
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of calmodulin in the regulation of dopamine receptor function.
    Hanbauer I; Memo M; Billingsley M
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():521-7. PubMed ID: 6328934
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.